1. 1. Majowicz, S.E., Musto, J., Scallan, E. et al. (2010): International Collaboration on Enteric Disease “Burden of Illness” Studies. The global burden of nontyphoidal Salmonella gastroenteritis. Clin. Infect. Dis., 50, 882–889.
2. 2. Miriagou, V., Tassios, P.T., Legakis, N.J., et al. (2004): Expanded-spectrum cephalosporin resistance in non-typhoid Salmonella. Int. J. Antimicrob. Agents, 23, 547–555.
3. 3. Giraud, E., Brisabois, A., Martel, J.L., et al. (1999): Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counter selection of highly fluoroquinolone-resistant strains in the field. Antimicrob. Agents Chemother., 43, 2131–2137.
4. 4. Clinical and Laboratory Standards Institute (2009): Performance standards for antimicrobials susceptibility testing; 19th Informational supplement M100-S19. Clinical and Laboratory Standards Institute. Wayne, Pa., USA.
5. 5. Ho, P.L., Chow, K.H., Yuen, K.Y., et al. (1998): Comparison of a novel, inhibitor-potentiated disc-diffusion test with other methods for the detection of extended-spectrum β-lactamases in Escherichia coli and Klebsiella pneumoniae. J. Antimicrob. Chemother., 42, 49–54.